The purpose of this study is to collect urine samples from patients with fibrodysplasia ossificans progressiva (FOP) for the assessment of biomarkers related to disease, disease progression and for prediction of flare-ups of the disease. Disease related biomarkers in these patients are currently unknown. This study aims to support the development of novel therapy/ies for this disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Analysis of pre-defined biomarker FGF2
Timeframe: 3 months
Analysis of pre-defined biomarker WEGF
Timeframe: 3 months
Analysis of microRNAs
Timeframe: 3 months